Chimerix Inc (NASDAQ:CMRX)
| 1.91 Delayed Data As of Jan 24 |  -0.08 / -4.02%Today’s Change | 1.25 Today|||52-Week Range 4.40 | -5.91% Year-to-Date |
Latest CMRX News | Press Releases
No recent news for Chimerix Inc.
Today’s Trading
| Previous close | 1.99 |
| Today’s open | 1.98 |
| Day’s range | 1.86 - 2.00 |
| Volume | 269,207 |
| Average volume (3 months) | 695,804 |
| Market cap | $125.2M |
Data as of 4:00pm ET, 01/24/2020
Growth & Valuation
| Earnings growth (last year) | +5.32% |
| Earnings growth (this year) | -9.44% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +60.57% |
| P/E ratio | NM |
| Price/Sales | 17.31 |
| Price/Book | 0.58 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FENCFennec Pharmaceutica... | -0.09 | -1.45% |
| PRTKParatek Pharmaceutic... | -0.11 | -3.03% |
| EPIXESSA Pharma Inc | 0.00 | 0.00% |
| ETONEton Pharmaceuticals... | -0.27 | -4.02% |
Data as of 4:00pm ET, 01/24/2020
Financials
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $7.2M |
| Annual profit (last year) | -$69.5M |
| Net profit margin | -962.78% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
